Nicotine dependence: studies with a laboratory model (Q34498036)

2 August 2017

1 reference

title

Nicotine dependence: studies with a laboratory model (English)

1 reference

2 August 2017

0 references

0 references

1 reference

Malin DH

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Pharmacology, Biochemistry and Behavior

2 August 2017

published in

1 reference

2 August 2017

volume

70

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

551-559

1 reference

Nitric oxide mediates mecamylamine- and naloxone-precipitated nicotine withdrawal

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Absorption and metabolism of nicotine from cigarettes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

A comparison of the effects of nicotine and (+)-amphetamine on rat behaviour in an unsignalled Sidman avoidance schedule.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Circadian blood nicotine concentrations during cigarette smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Effects of nicotine administration and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Nicotine dependence in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Nicotine self-administration in animals as a dependence model

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Selective dopamine antagonists reduce nicotine self-administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Evidence for a behavioral deficit during withdrawal from chronic nicotine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

The actions of nicotine and cocaine in a mouse model of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Sites of action of ondansetron to inhibit withdrawal from drugs of abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Animal models of drug withdrawal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Dramatic decreases in brain reward function during nicotine withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Schedule-controlled behavior in the morphine-dependent rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Effects of nicotine withdrawal on central dopaminergic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Subjective correlates of cigarette-smoking-induced elevations of peripheral beta-endorphin and cortisol.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Central dopamine involvement in experimental gastrointestinal injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Effects of nicotine on body weight and food consumption in female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Withdrawal from chronic nicotine substitutes partially for the interoceptive stimulus produced by pentylenetetrazol (PTZ).

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Tobacco withdrawal symptoms: an experimental analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor reactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Plasma enkephalin-like peptide response to chronic nicotine infusion in guinea pig

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Intraaccumbal mecamylamine infusion does not affect dopamine output in the nucleus accumbens of chronically nicotine-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Physical dependence on nicotine in gum. A placebo substitution trial

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Nicotine abstinence in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Characterization of a dose-response curve for nicotine-induced conditioned taste aversion in rats: relationship to elevation of plasma beta-endorphin concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Chronic nicotine and withdrawal effects on body weight and food and water consumption in female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Correlation between brain nitric oxide synthase activity and opiate withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Cerebrospinal fluid from morphine-dependent rats precipitates opiate abstinence syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Auricular microelectrostimulation: naloxone-reversible attenuation of opiate abstinence syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

FMRF-NH2-like mammalian octapeptide: possible role in opiate dependence and abstinence.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Rodent model of nicotine abstinence syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Subcutaneous injection of an analog of neuropeptide FF precipitates morphine abstinence syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Naloxone precipitates nicotine abstinence syndrome in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Subcutaneous injection of an analog of neuropeptide FF prevents naloxone-precipitated morphine abstinence syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Nicotine abstinence syndrome precipitated by an analog of neuropeptide FF

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Nicotine abstinence syndrome precipitated by central but not peripheral hexamethonium.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

The nitric oxide synthesis inhibitor nitro-L-arginine (L-NNA) attenuates nicotine abstinence syndrome in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Nicotine abstinence syndrome precipitated by the competitive nicotinic antagonist dihydro-beta-erythroidine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Nicotine withdrawal in the rat: role of alpha7 nicotinic receptors in the ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Neuroendocrine reactivity to nicotine in smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Biphasic effects of chronic nicotine treatment on hypothalamic immunoreactive beta-endorphin in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Smoking withdrawal symptoms in two weeks of abstinence

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Mecamylamine-precipitated nicotine-withdrawal aversion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Attenuation of mecamylamine-precipitated nicotine-withdrawal aversion by the 5-HT3 receptor antagonist ondansetron.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Mecamylamine-precipitated nicotine-withdrawal aversion in Lewis and Fischer 344 inbred rat strains

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Nicotine replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Contribution of glutamate receptors to benzodiazepine withdrawal signs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Effects of withdrawal from long-term nicotine gum use

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

Does switching to an ultra-low nicotine cigarette induce nicotine withdrawal effects?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900699-2

7 January 2021

10.1016/S0091-3057(01)00699-2

Identifiers

DOI

1 reference

2 August 2017

1 reference